News

22/11/2017

Medicijnen in de Tweede Kamer

Vandaag vindt in de Tweede Kamer een Algemeen Overleg geneesmiddelenbeleid plaats. Vooruitlopend op het overleg organiseerde Wemos vorige week in de Tweede Kamer een bijeenkomst over het belang van voorwaarden verbinden aan publieke investeringen in medicijnen. Read more

Blog

16/11/2017

Why lack of money is draining African health sectors

If you had to wait twelve hours to pay a visit to your physician, would you return the next time? Or if a midwife yelled at you during labour, or your prescription drugs were never available at your local pharmacy? In the African health sector, these scenarios are not uncommon. We talked about health care in Africa with the Nigerian PhD student Oluwasegun Jko Ogundele, who paid a visit to Wemos earlier this month. Read more

News

26/10/2017

Global health cafes: join the debate on health workers

A new series of global health debates – Global Health Cafes – will kick off on Monday November 20th at the Royal Tropical Institute (KIT). The series is a joint collaboration between Vice Versa, Wemos and other civil society organizations. Read more

News

12/10/2017

European medicines agency must protect vulnerable clinical trial participants

In a letter to the director of the European Medicines Agency (EMA), three Members of European Parliament (MEPs) have expressed their concerns about vulnerable clinical trial participants in low- and middle-income countries. Read more

News

5/10/2017

European Parliament rejects criteria endocrine-disrupting chemicals

The European Parliament has rejected the European Commission’s proposed criteria for identifying endocrine-disrupting chemicals. These criteria, in their current form, would not sufficiently protect our health. Read more

News

28/9/2017

EU criteria for endocrine-disrupting chemicals will not protect health

The European Commission’s proposed criteria for identifying endocrine-disrupting chemicals should be amended, as they will not protect the health of European citizens. Read more

News

13/9/2017

Action plan for sustainable health workforce policy in European region

the 67th session of European member states of the World Health Organization (WHO). In a statement that she delivered on behalf of Medicus Mundi International (MMI), Wemos global health advocate Linda Mans stressed that without investments in health workforce, guaranteeing health security and universal access to health will be an impossible task. Read more

Blog

24/7/2017

We cannot allow this plan to fail: invest in health workforce

With changing lifestyles and ageing population, chronic diseases have become increasingly common. Bearing this in mind, it has been predicted that by the year 2030, there will be a demand for 40 million new jobs in healthcare worldwide, most of these in high-income countries. In this same period, the shortage of health workforce in low-income countries will have grown to 18 million. Read more

News

4/7/2017

Unethical clinical trials in Africa

Clinical trials in Africa are not always conducted according to leading ethical guidelines. This puts clinical trial participants at risk of being physically harmed or having their rights violated. Read more